ProQR Therapeutics N.V. Share Premium
ProQR Therapeutics N.V. (PRQR) had Share Premium of EUR 483.88 million as of 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Notes
ifrs-full:SharePremium · last filed 2026-03-12
- 2025-12-31: Share Premium 483.88M EUR.
- 2024-12-31: Share Premium 483.81M EUR.
- 2023-12-31: Share Premium 412.89M EUR.
- 2022-12-31: Share Premium 412.54M EUR.
| Period end | Share Premium |
|---|---|
| 2025-12-31 | 483.88M EUR 20-F · filed 2026-03-12 |
| 2024-12-31 | 483.81M EUR 20-F · filed 2026-03-12 |
| 2023-12-31 | 412.89M EUR 20-F · filed 2025-03-13 |
| 2022-12-31 | 412.54M EUR 20-F · filed 2024-03-13 |
| 2021-12-31 | 398.31M EUR 20-F · filed 2023-03-29 |
| 2020-12-31 | 288.76M EUR 20-F · filed 2022-04-29 |
| 2019-12-31 | 287.21M EUR 20-F · filed 2021-03-24 |
| 2018-12-31 | 235.74M EUR 20-F · filed 2020-03-31 |
| 2017-12-31 | 148.76M EUR 20-F · filed 2019-03-28 |
| 2016-12-31 | 123.60M EUR 20-F · filed 2018-03-30 |